DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 022370
» See Plans and Pricing
The generic ingredient in CONZIP is tramadol hydrochloride. There are thirty-six drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the tramadol hydrochloride profile page.
Summary for 022370
Tradename: | CONZIP |
Applicant: | Cipher Pharms Inc |
Ingredient: | tramadol hydrochloride |
Patents: | 1 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 022370
Mechanism of Action | Full Opioid Agonists |
Medical Subject Heading (MeSH) Categories for 022370
Suppliers and Packaging for NDA: 022370
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370 | NDA AUTHORIZED GENERIC | Trigen Laboratories, LLC | 13811-689 | 13811-689-30 | 30 CAPSULE in 1 BOTTLE, PLASTIC (13811-689-30) |
CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370 | NDA AUTHORIZED GENERIC | Trigen Laboratories, LLC | 13811-690 | 13811-690-30 | 30 CAPSULE in 1 BOTTLE, PLASTIC (13811-690-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 100MG | ||||
Approval Date: | May 7, 2010 | TE: | RLD: | Yes | |||||
Patent: | Start Trial | Patent Expiration: | Apr 11, 2022 | Product Flag? | Y | Substance Flag? | Delist Request? |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 200MG | ||||
Approval Date: | May 7, 2010 | TE: | RLD: | Yes | |||||
Patent: | Start Trial | Patent Expiration: | Apr 11, 2022 | Product Flag? | Y | Substance Flag? | Delist Request? |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 300MG | ||||
Approval Date: | May 7, 2010 | TE: | RLD: | Yes | |||||
Patent: | Start Trial | Patent Expiration: | Apr 11, 2022 | Product Flag? | Y | Substance Flag? | Delist Request? |
Complete Access Available with Subscription